Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S278000, C514S301000, C514S252160, C514S234200, C544S255000, C544S117000, C544S121000, C546S114000, C546S016000, C546S018000
Reexamination Certificate
active
07947692
ABSTRACT:
There are presented compounds of the formulaor a pharmaceutically acceptable salt thereof, which are active adenosine A2B receptor antagonists and useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea.
REFERENCES:
patent: 6060481 (2000-05-01), LaNoue et al.
patent: 1 3 88 341 (2004-02-01), None
patent: WO 03/053946 (2003-07-01), None
patent: WO 2005/070926 (2005-08-01), None
patent: WO 2005/100353 (2005-10-01), None
patent: WO 2006/013054 (2006-02-01), None
Brinkman John A.
Cheung Adrian Wai-Hing
Firooznia Fariborz
Guertin Kevin Richard
Marcopulos Nicholas
Hoffmann-La Roche Inc.
Johnston George W.
Moore Susanna
Tramaloni Dennis P.
LandOfFree
Substituted thiazolo[5,4-d]pyrimidine urea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thiazolo[5,4-d]pyrimidine urea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thiazolo[5,4-d]pyrimidine urea derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2637685